M&A Deal Summary |
|
|---|---|
| Date | 2022-05-02 |
| Target | Euprotein |
| Sector | Life Science |
| Buyer(s) | Meridian Bioscience |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1976 |
| Sector | Life Science |
| Employees | 702 |
| Revenue | 318M USD (2021) |
Meridian is a life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Meridian was founded in 1976 and is based in Cincinnati, Ohio.
| DEAL STATS | # |
|---|---|
| Overall | 11 of 11 |
| Sector: Life Science M&A | 5 of 5 |
| Type: Add-on Acquisition M&A Deals | 7 of 7 |
| State: New Jersey M&A | 2 of 2 |
| Country: United States M&A | 8 of 8 |
| Year: 2022 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-07-23 |
Otsuka America Pharmaceutical - North American BreathTek business
Princeton, New Jersey, United States Otsuka America Pharmaceutical's North American BreathTek business is a urea breath test for the detection of Helicobacter pylori. Otsuka America Pharmaceutical's North American BreathTek business is based in Princeton, New Jersey. |
Buy | $20M |